¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"split skin graft"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • skin friction
    ÇǺθ¶Âû
  • skin lesion
    ÇǺκ´ÅÍ, ÇǺÎȯºÎ
  • skin line
    ÇǺμ±
  • skin manifestation
    ÇǺμҰß
  • skin muscle approach
    ÇǺαÙÀ°Á¢±Ù¹ý
  • skin reaction
    ÇǺιÝÀÀ
  • skin reflex
    ÇǺιݻç
  • skin retinaculum
    ÇǺÎÁöÁö¶ì
  • skin scraping
    ÇǺÎÂû°úÇ¥º»
  • skin sensitization
    ÇǺιΰ¨È­
  • skin slough
    ÇǺεüÁö
  • skin sparing
    ÇǺκ¸Á¸
  • skin tag
    ÁãÁ¥
  • skin tension line
    ÇǺαäÀå¼±
  • skin vascular permeability factor
    ÇǺÎÇ÷°üÅõ°úÀÎÀÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • galvanic skin reflex
    Àü±âÇǺιݻç
  • galvanic skin response
    Àü±âÇǺιÝÀÀ
  • glabrous skin
    Åоø´ÂÇǺÎ
  • glossy skin
    ±¤ÅÃÇǺÎ
  • goose flesh skin
    ¼Ò¸§
  • gravitational skin line
    Áß·ÂÇǺμ±
  • hairy skin receptor
    ÅÐÇǺμö¿ëü
  • infantile stiff skin syndrome
    ¿µ¾ÆÇǺΰæÁ÷ÁõÈıº
  • leopard skin
    Ç¥¹üÇǺÎ
  • lizard skin
    µµ¸¶¹ìÇǺÎ
  • relaxed skin tension line
    ÇǺÎÇ®¸²¼±, ÇǺÎÀ̿ϼ±
  • skin lesion
    ÇǺκ´ÅÍ, ÇǺÎȯºÎ
  • skin line
    ÇǺμ±
  • skin tension line
    ÇǺαäÀå¼±
  • skin manifestation
    ÇǺμҰß
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • graft rejection, white
    ¹é»öÈ­ ÀÌ½ÄÆí°ÅºÎ (Ãʱ޼º)
  • graft schizophrenia See schizophrenia
    Á¢Áö<Á¢¸ñ>Á¤½ÅºÐ¿­º´<Áõ> (ïÈò«<ïÈÙÊ>ïñãêÝÂæñÜ»<ñø>)
  • graft versus host disease
    ´ë¼÷ÁÖÀÌ½ÄÆíÁúȯ
  • graft versus host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´.
  • graft versus host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´
  • graft versus host reaction
    ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀ(ì¹ãÕø¸ÓßâÖñ«Úãëë).
  • graft versus host reaction (GVHR)
    ´ë¼÷ÁÖÀÌ½ÄÆí¹ÝÀÀ
  • graft, free jejunal
    À¯¸®°øÀå À̽ļú
  • graft, heterotopic
    À̼ÒÀ̽Ä, ´Ù¸¥ÀÚ¸®À̽Ä
  • graft, nerve
    ½Å°æÀ̽Ĺý
  • graft, orthotopic
    µ¿¼ÒÀ̽Ä, °°ÀºÀÚ¸®À̽Ä
  • graft, perichondral cutaneous
    ¿¬°ñ¸·ÇǺÎÀ̽Ä
  • graft, second
    ÀÌÂ÷À̽Ä
  • graft-versus-host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´
  • graft-versus-host disease
    ÀÌ½ÄÆí´ë ¼÷ÁÖº´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • coronary artery bypass graft
    °ü»óµ¿¸Æ¿ìȸ·Î¼úÀ̽Ä(¼ú).
  • coronary artery bypass graft
    °ü»óµ¿¸Æ¿ìȸ·Î¼úÀ̽Ä(¼ú).
  • cultured keratinocyte graft
    ¹è¾ç°¢Áú¼¼Æ÷ À̽Ä
  • dermic graft
    ½ÄÇÇ(½ÄÇÇ).
  • dermis graft
    ÁøÇÇÀ̽Ä
  • double-end graft
    ½Ö´ÜÀ̽Ä.
  • dural graft
    °æ¸·À̽Ä(°æ¸·À̽Ä).
  • epidermic graft
    Ç¥ÇÇÀ̽Ä(¡­ì¹ãÕ).
  • fascia graft
    ±Ù¸· À̽Ä(ÐÉØ¯ì¹ãÕ).
  • fat graft
    Áö¹æÀÌ½ÄÆí(¡­ÀÌ½ÄÆí).
  • fat graft
    Áö¹æÀ̽Ä
  • fat graft
    Áö¹æÀÌ½ÄÆí(¡­ì¹ãÕø¸).
  • free graft
    À¯¸®À̽Ä(ë´ìÆì¹ãÕ).
  • free graft
    À¯¸®À̽Ä(À¯ÀÌÀ̽Ä).
  • free jejunal graft
    À¯¸®°øÀå À̽ļú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
ST esotropia; scala tympani; scaphotrapezoid; sclerotherapy; sedimentation time; semitendinosus; sensor...
STD selective T-cell defect; sexually transmitted disease; skin-to-tumor distance; skin test dose; sodiu...
JP drain The original suction drain. The drain itself is inside the body. It is made of Teflon and has multip...
FDP(s)   1) Fibrinolytic split Products(= FSP)
  2) Fibrinogen Degradation Products
FSP Fibrin Split Product
  = FDPs
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
GVHD Graft Versus Host Disease
GvHR Graft v Host Reaction
GVD Graft vascular disease
GvH Graft versus Host
GVH Graft versus host reaction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • perichondral bony ring

    perichondral cutaneous graft

    ¿¬°ñ¸· ÇǺΠÀ̽Ä
  • periosteal graft
    °ñ¸· À̽Ä, °ñ¸· ÀÌ½ÄÆí
    °ñÀÇ ¹þ°ÜÁø ºÎÀ§¿¡ »ç¿ëµÇ´Â °ñ¸·Æí.
  • Phemister graft
    Æä¹Ì½ºÅÍ À̽Ä
    ÇÇÁú°ñ ÀÌ½Ä ½Ã¿¡ ÇØ¸é ¼¼Á°ñ À̽ÄÀ» °°ÀÌÇÏ¸é °¡°ñ Çü¼ºÀÌ ÀߵȴÙ.
  • pinch graft
    ÇÉÄ¡ À̽Ä
    Á÷°æ 0.25ÀÎÄ¡ÀÇ ÇÇºÎÆí. ħÀ¸·Î ÇǺθ¦ µé¾î¿Ã·Á Ä®·Î ¾ã°Ô Àß¶ó¼­ ¾ò´Â´Ù. µÎ²²´Â ÀÌ½ÄÆí¸¶´Ù ´Ù¸£³ª Áö¹æÀº ºÙ¾îÀÖÁö ¾Ê´Ù.
  • sieve graft
    »ç»ó À̽Ä
    ¿øÇüÀÇ ¾ÆÁÖ ÀÛÀº ¸î °³ÀÇ µµ°¡ Á¦°ÅµÈ ÇǺΠÀÌ½ÄÆí. ÀÌ´Â Å« ³ëÃâµÈ ºÎÀ§¸¦ µ¤´Âµ¥ »ç¿ëµÈ´Ù.
  • xenogenic graft
    ÀÌÁ¾À̽Ä
    ÀÌÁ¾ÀÇ µ¿¹°°£¿¡ À̽ÄÇÏ´Â °Í.
  • xenogenous graft
    ÀÌÁ¾ ÀÌ½ÄÆí
    ÀÌÁ¾ÀÇ µ¿¹°°£¿¡ À̽ĵǴ ½ÃÆí.
  • abdominal skin reflex
    º¹ºÎ ÇǺΠ¹Ý»ç
    º¹º®À» Á߾Ӻο¡¼­ ¿ÜÃøÀ» ÇâÇØ¼­ ¼±»óÀ¸·Î ¹®Áö¸£¸é º¹±Ù, ƯÈ÷ ¿Üº¹»ç±ÙÀÌ ¼öÃàÀ» ÀÏÀ¸Å°´Â Çö»ó. ¹Ý»ç ÁßÃß´Â T7¿¡¼­ T12¿¡ ÀÖ´Ù. ¹Ý»ç±ÃÀÇ ÀϺδ ´ë³ú¸¦ Åë°úÇÑ´Ù. ´Ù¹ß¼º °æÈ­ÁõÀÇ °æ¿ì¿¡ ÀÌ ¹Ý»ç°¡ ¼Ò½ÇµÇ¸é, ÁÖü·ÎÀÇ Àå¾Ö¿¡ ÀÇÇØ °¨¼Ò, ¼Ò½ÇµÈ´Ù. °Ç°­ÇÑ »ç¶÷¿¡°Ôµµ º¹º®ÀÇ ÀÌ¿ÏÀÚ, Áö¹æ °ú´Ù, ³ëÀÎ, À¯¾Æ µî¿¡¼­ °á¿©µÇ´Â °æ¿ì°¡ ÀÖ´Ù.
  • atrophic skin
    À§Ã༺ ÇǺÎ
  • bullous skin disease
    ¼öÆ÷¼º ÇǺΠÁúȯ
  • chapping of skin
    ÇǺΠ±Õ¿­
  • circumscribed flat skin elevation
    ±¹ÇѼº ÆíÆò ÇǺΠÀ¶±â
  • elastic skin
    ź¼º ÇǺÎ, ź·Â¼º ÇǺÎ, °í¹«¾ç ÇǺÎ
    ÇǺΠÇü¼º ÀÌ»óÁõÀÇ ÀÏÁ¾, ¿¤·¯½º-´Ü·Î½º ÁõÈıº¿¡ ÃâÇö.
  • excited skin syndrome
    ÈïºÐ¼º ÇǺΠÁõÈıº
  • flat skin plaque
    ÆíÆò ÇǺΠ¹Ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
graft survival <haematology> The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host.
(12 Dec 1998)
graft-versus-host disease <haematology> A common and serious, complication of bone marrow transplantation where there is a reaction of donated bone marrow against a patient's own tissue.
When donor lymphocytes or a graft containing lymphocytes that are immunologically competent are given to a patient that has low immunological competence, an incompatibility reaction can result. This is due to antibodies from the donor against antigens in the host. This is due to mismatch of MHC Class I antigens and can produce lymphocyte clones that will react by a variety of processes against the host and cause damage.
The clinical condition can be fatal and is due to the donor's immune cells recognising the host cells as foreign.
The clinical entity characterised by anorexia, diarrhoea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the graft-versus-host reaction. It can occur in either chronic or acute forms and is treatable by immunosuppressive drugs.
Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.
Radiological appearances of the gastrointestinal tract include; thickened wall, mucosal folds thickened or effaced, increased secretions most likely to be rapid transit of GI tract, mass most likely to be focal oedema, fibrosis, hallmark: diffuse, uniform thickening of small bowel.
Synonym: GVH disease.
Acronym: GVHD
(20 Sep 2002)
graft-versus-host reaction <haematology> A common and serious, complication of bone marrow transplantation where there is a reaction of donated bone marrow against a patient's own tissue.
When donor lymphocytes or a graft containing lymphocytes that are immunologically competent are given to a patient that has low immunological competence, an incompatibility reaction can result. This is due to antibodies from the donor against antigens in the host. This is due to mismatch of MHC Class I antigens and can produce lymphocyte clones that will react by a variety of processes against the host and cause damage.
The clinical condition can be fatal and is due to the donor's immune cells recognising the host cells as foreign.
The clinical entity characterised by anorexia, diarrhoea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the graft-versus-host reaction. It can occur in either chronic or acute forms and is treatable by immunosuppressive drugs.
Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.
Radiological appearances of the gastrointestinal tract include; thickened wall, mucosal folds thickened or effaced, increased secretions most likely to be rapid transit of GI tract, mass most likely to be focal oedema, fibrosis, hallmark: diffuse, uniform thickening of small bowel.
Synonym: GVH disease.
Acronym: GVHD
(20 Sep 2002)
graft-versus-host response <haematology> A common and serious, complication of bone marrow transplantation where there is a reaction of donated bone marrow against a patient's own tissue.
When donor lymphocytes or a graft containing lymphocytes that are immunologically competent are given to a patient that has low immunological competence, an incompatibility reaction can result. This is due to antibodies from the donor against antigens in the host. This is due to mismatch of MHC Class I antigens and can produce lymphocyte clones that will react by a variety of processes against the host and cause damage.
The clinical condition can be fatal and is due to the donor's immune cells recognising the host cells as foreign.
The clinical entity characterised by anorexia, diarrhoea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the graft-versus-host reaction. It can occur in either chronic or acute forms and is treatable by immunosuppressive drugs.
Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.
Radiological appearances of the gastrointestinal tract include; thickened wall, mucosal folds thickened or effaced, increased secretions most likely to be rapid transit of GI tract, mass most likely to be focal oedema, fibrosis, hallmark: diffuse, uniform thickening of small bowel.
Synonym: GVH disease.
Acronym: GVHD
(20 Sep 2002)
mesh graft A skin graft in which multiple slits have been made, so it can be stretched to cover a large area.
Synonym: mesh graft.
(05 Mar 2000)
periosteal graft A graft of periosteum, usually placed on bare bone.
(05 Mar 2000)
chip graft A graft utilizing small pieces of cartilage or bone which is packed into a bone defect.
(05 Mar 2000)
chorioallantoic graft Transplanting of living material to the chorioallantoic membrane of the embryonic chick.
(05 Mar 2000)
Phemister graft An autogenous onlay bone graft used in treating delayed union of fractures.
(05 Mar 2000)
pinch graft Small bits of skin, of partial or full thickness, removed from a healthy area and seeded in a site to be covered.
Synonym: Reverdin graft.
(05 Mar 2000)
white graft Rejection of a skin allograft so acute that vascularization never occurs.
(05 Mar 2000)
composite graft A graft composed of several structures, such as skin and cartilage or a full-thickness segment of the ear.
(05 Mar 2000)
mucosal graft A graft of mucous membrane, usually the full-thickness of the lining of the cheek or lower lip.
(05 Mar 2000)
Wolfe graft A full-thickness skin graft without any subcutaneous fat.
Synonym: Wolfe-Krause graft.
(05 Mar 2000)
Wolfe-Krause graft A full-thickness skin graft without any subcutaneous fat.
Synonym: Wolfe-Krause graft.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á